drugset
drugset / Trial / NCT06290596

Vasopressin Versus Tranexamic Acid for Control of Blood Loss Related to Abdominal Hysterectomy

NCT06290596 ↗

Phase 4 Unknown 387 enrolled Al-Azhar University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

To find the best option to reduce blood loss related to abdominal hysterectomy (AH), the present randomized double-blinded study sought to compare the effects of locally administered vasopressin (VP) and tranexamic acid (TXA) on blood loss in women submitted to AH for benign lesions.

Timeline

Start
2024-04-01
Primary completion
2024-10-01
Completion
2024-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 1.5 g Topical
Subject Vasopressin Peptide 10 iu Other

Indications

uterine disorder